<?xml version="1.0" encoding="utf-8"?><svg:svg xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:svg="http://www.w3.org/2000/svg" version="1.1" width="595.22px" height="842px" preserveAspectRatio="none" viewBox="0 0 595.22 842"><svg:defs><svg:clipPath id="--clippath0" transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:clipPath><svg:style type="text/css">@font-face { font-family: "g_d0_f1";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f2";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f3";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f4";; src: url(data:font/woff;base64,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); }  @font-face { font-family: "g_d0_f5";; src: url(data:font/woff;base64,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); } </svg:style></svg:defs><svg:g transform="matrix(1 0 0 -1 0 842)"><svg:g transform=""><svg:path d="M 0 0 L 595.22 0 L 595.22 842 L 0 842 Z" stroke-miterlimit="0" stroke-linecap="" stroke-linejoin="" stroke-width="1px" stroke-dasharray="" stroke-dashoffset="0px" fill="none" clip-rule="nonzero"></svg:path></svg:g><svg:g clip-path="url(#clippath0)"><svg:g transform=""><svg:text transform="matrix(11 0 0 11 231.376 780.8953) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.593 1.113 1.295 1.8 2.307 2.812 3.329 3.83 4.18 4.702 5.224 5.52 6.042 6.38 7.077 7.599 7.937 8.454 8.955 9.305 9.791 10.313 10.627 11.149 11.499 11.669 12.186 12.687 13.037 13.552 13.89 14.407 14.841 15.363 15.864 16.381 16.882 17.232 17.414 17.936 18.232 18.754 19.188 19.622 19.804 20.321 20.822 21.339 21.84 22.19 22.702 23.052 23.366 23.704 24.19 24.712 25.213 25.91 26.112 26.613 26.795 27.341 27.511 28.033" font-family="g_d0_f1" font-size="1px" fill="rgb(43,46,52)">Cuidados enfermeros ante los procesos infecciosos y transmisibles</svg:tspan></svg:text><svg:text transform="matrix(7.5 0 0 7.5 536.703 52.9521) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.556 1.112" font-family="g_d0_f2" font-size="1px" fill="rgb(43,46,52)">483</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 360.577) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.25" x="0 0.722 1.333 1.944 2.5 2.889 3.445 4.056 4.556 4.834 5.39 5.668 6.224 6.502 6.78 7.113 7.502 8.058 8.391 8.947 9.891 10.169 10.725 11.336 11.669 12.28 12.558 13.114 13.725 14.058 14.336 14.701 15.09 15.646 15.979 16.368 16.964 17.52 17.798 18.187 18.743" font-family="g_d0_f2" font-size="1px" fill="rgb(64,198,192)">Adherencia al tratamiento antirretroviral</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 338.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 338.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.172 1.415 1.637 2.081 2.324 2.713 3.157 3.601 4.045 4.434 4.656 5.1 5.544 5.988 6.231 6.675 7.119 7.341 7.584 8.028 8.472 8.861 9.083 9.527 9.971 10.249 10.693 10.936 11.38 11.824 12.102 12.546 12.789 13.011 13.678 14.122 14.344 14.566 14.955 15.399 15.677 16.066 16.51 16.753 17.142 17.586 17.864 18.142 18.586 18.975 19.253 19.697 20.364 20.808 21.252 21.53 21.974 22.217 22.661 23.105 23.348 23.57 24.014 24.257 24.701 24.923 25.367 25.756 26.145 26.367 26.811 27.255 27.477 27.72 27.942 28.386 28.608 28.997 29.219 29.663 29.906 30.295 30.538 30.927 31.371 32.038 32.482 32.704 32.926 33.593 33.815 34.259 34.703 34.981 35.425 35.668 36.112 36.556 36.778 37.021 37.299 37.577 38.021 38.299 38.743 39.41 39.632 40.076 40.52 40.798 41.242 41.464 41.707 42.151 42.394 42.616 42.838 43.282 43.525 43.969 44.413 44.656 45.045 45.489" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Es la capacidad del paciente para implicarse correctamente en la elección, inicio y cumplimiento del tratamiento, a ﬁ n de con</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 489.702603 338.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.721 1.943 2.221 2.464 2.908 3.352 3.796" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">seguir una </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.370114 327.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.721 2.165 2.609 3.053 3.497 3.719 4.108 4.552 4.996 5.274 5.718 6.107 6.329 6.773 7.217 7.439 7.883 8.327 8.549 8.771 9.215 9.437 9.715 10.159 10.603 10.825 11.047 11.436 11.88 12.269 12.491 12.935 13.379 13.601 13.99 14.212 14.49 14.934 15.156 15.378" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">adecuada supresión de la replicación viral. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 316.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.227 1.505 1.783 2.227 2.449 2.671 3.115 3.504 3.726 4.004 4.448 4.837 5.115 5.559 5.837 6.281 6.67 6.892 7.336 7.725 8.169 8.558 8.78 9.224 9.668 10.112 10.501 10.723 11.112 11.556 12 12.222 12.889 13.333 13.555 13.999 14.221 14.665 15.109 15.553 15.997 16.275 16.719 17.163 17.552 17.774 18.218 18.44 18.884 19.328 19.717 19.995 20.439 20.828 21.272 21.716 21.938" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Entre los factores asociados con mala adherencia destacan: </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 305.8383) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.723 2.167 2.389 2.833 3.055 3.333 3.777 3.999 4.443 4.832 5.054 5.498 5.942 6.164 6.831 7.275 7.719 7.941 8.33 8.774 9.052 9.496 9.94 10.329 10.551 10.995 11.439 11.717 12.161 12.383" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Mala relación médico-paciente. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 294.8385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.333 2.722 3.166 3.833 4.277 4.499 4.943 5.387 5.609 6.053 6.331 6.775 7.219 7.663 8.052 8.274" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Consumo de drogas. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 283.8387) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.3889 1.8329 2.1109 2.5549 2.8329 3.4999 3.9439 4.3879 4.8319 5.2759 5.4978 6.1648 6.6088 7.0528 7.3308 7.7748 7.9968" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Enfermedad mental.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 272.8389) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.445 1.889 2.111 2.555 2.777 3.221 3.443 3.832 4.276 4.498 4.72 5.164 5.608 6.052 6.441 6.885 7.163 7.385 7.774 8.218 8.44" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Bajo nivel educativo. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 261.8391) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.4449 1.8889 2.1669 2.4449 2.8889 3.1669 3.6109 3.8328 4.0548 4.4988 4.7208 5.1648 5.8318 6.2758 6.5538 6.7758 7.1648 7.6088" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Barrera idiomática.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 250.8393) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.334 1.778 2 2.278 2.722 2.944 3.388 3.832 4.054 4.498 4.942 5.386 5.775 6.219 6.441 6.83 7.274 7.663 7.885 8.329 8.551" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Falta de apoyo social.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 239.8395) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.9449 1.4449 1.8889 2.5559 2.9999 3.2219 3.6659 3.8879 4.1099 4.5539 4.9979 5.4419" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Complejidad.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.3701 228.8397) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.278 0.945 1.389 1.667 2.111 2.5 2.778 3.222 3.611 3.833 4.222 4.666 5.055 5.499 5.943 6.387 6.831 7.109 7.331 7.775 8.164 8.386 8.83 9.274 9.496 9.718 9.996 10.274 10.718 10.996 11.44 12.107 12.329 12.773 13.217 13.495 13.939 14.161 14.383 14.827 15.271 15.549 15.827 16.271 16.493 16.937 17.215 17.493 17.937 18.326" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">- Efectos secundarios del tratamiento, entre otros.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 206.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 206.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3386 0.7826 1.0046 1.2812 1.7252 2.1692 2.6132 3.0022 3.4462 3.7228 4.1668 4.8338 5.2778 5.6668 5.8888 6.3328 6.7768 7.2208 7.4428 7.7194 8.1084 8.385 8.774 8.996 9.274 9.718 9.94 10.162 10.4386 10.6606 11.1046 11.3812 11.7702 12.2142 12.6582 13.1022 13.4912 13.7132 14.1572 14.6012 15.0452 15.3218 15.7658 16.2098 16.4878 16.9318 17.2084 17.4304 17.8744 18.2634 18.4854 18.9294 19.1514 19.4294 19.706 19.928 20.372 20.6486 21.3156 21.7596 22.2036 22.4256 22.8146 23.2586 23.6476 23.8696 24.3136 24.7576 25.0342 25.4782 25.9222 26.1988 26.4208 26.8648 27.1414 27.5304 27.7524 28.1964 28.6404 28.917 29.361 29.583 30.027 30.305 30.527 30.971 31.2476 31.6366 31.9132 32.1352 32.5792 32.8558 33.2448 33.6888 34.3558 34.7998 35.0778 35.5218 35.9658 36.3548 36.5768 37.0208 37.4648 37.7414 38.1854 38.6294 38.906 39.128 39.572 39.8486 40.1266 40.5706 40.7926 41.2366 41.6256 41.8476 42.2916 42.7356 43.0122 43.4562 43.9002 44.1782 44.4562 44.9002 45.1768 45.6208" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> El apoyo emocional y vital, la capacidad para incluir la medicación en la vida diaria y la comprensión de la relación entre ad</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 490.895993 206.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.166 1.61 2.054 2.443 2.665 3.109 3.3856 3.7746" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">herencia y </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.370079 195.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.721 1.999 2.277 2.721 2.943 3.165 3.609 3.831 4.275 4.719 4.941 5.219 5.663 6.052 6.274 6.663 6.941 7.385 7.829 8.218 8.44 8.884 9.273 9.495 9.884 10.328 10.772 10.994 11.272 11.716 12.105 12.383 12.827 13.105 13.549 13.938 14.16 14.604 15.048 15.492 15.714 16.158 16.436 16.88 17.324 17.546 17.935 18.379 18.823 19.045 19.489 19.933 20.377 20.599 21.043 21.487 21.931 22.375 22.653 23.097 23.541 23.93 24.152 24.596 24.818 25.207 25.651 25.929 26.207 26.651 27.04 27.318 27.762 27.984" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">desarrollo de resistencias son factores que predicen una adherencia correcta. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 184.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.23 184.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.349 0.839 1.273 1.652 2.086 2.52 2.899 3.167 3.601 3.813 4.247 4.459 4.671 5.105 5.317 5.751 6.185 6.619 7.053 7.265 7.477 7.856 8.29 8.502 8.936 9.37 9.582 10.016 10.45 10.829 11.263 11.697 11.965 12.233 12.667 13.101 13.535 13.747 14.181 14.615 15.049 15.317 15.529 15.908 16.342 16.999 17.433 17.645 17.857 18.514 18.726 19.16 19.594 19.862 20.296 20.508 20.942 21.376 21.588 22.022 22.456 22.835 23.047 23.481 23.915 24.183 24.617 24.996 25.208 25.865 26.299 26.678 26.89 27.102 27.536 27.915 28.349 28.783 29.217 29.596 29.808 30.187 30.399 31.056 31.49 31.702 32.136 32.404 32.616 32.995 33.429 34.086 34.52 34.732 34.944 35.601 35.813 36.247 36.681 36.949 37.383 37.595 38.029 38.463 38.675 39.109 39.543 39.922 40.134 40.568 41.002 41.27 41.704 42.083 42.295 42.952 43.386 43.765 44.199 44.467 44.901 45.28 45.492 45.926 46.36 46.572" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Respecto a la edad, se ha encontrado peor cumplimiento en pacientes muy jóvenes y mejor cumplimiento en pacientes mayores de 6</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 499.268692 184.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.434 0.646 1.08 1.514 1.948 2.327" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">5 años.</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 173.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 173.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.3392 0.8952 1.3392 1.6172 2.0612 2.4502 2.7174 3.1614 3.6054 3.8726 4.0946 4.5386 4.7606 5.1496 5.3716 5.8156 6.0936 6.3608 6.8048 7.0268 7.294 7.688 8.244 8.744 9.0112 9.4002 9.8442 10.2882 10.6772 10.8992 11.3432 11.7872 12.2312 12.4984 12.9424 13.2204 13.6644 14.1084 14.5524 14.8304 15.2744 15.5524 15.8196 16.2636 16.4856 16.7528 17.1968 17.6408 18.0298 18.2518 18.6958 19.1398 19.4178 19.8618 20.0838 20.351 20.573 21.017 21.461 21.905 22.183 22.405 22.627 22.8492 23.2382 23.6822 23.9602 24.2274 24.4494 24.8934 25.2824 25.5496 25.9386 26.1606 26.4386 26.8826 27.3266 27.7156 27.9376 28.3816 28.8256 29.2696 29.6586 29.9258 30.3698 30.8138 31.2578 31.525 31.969 32.413 32.857 33.301 33.745 34.189 34.4562 34.9002 35.1222 35.3442 35.5664 35.9554 36.3994 36.6214 36.8994 37.3434 37.6214 37.8886 38.1106 38.5546 38.8218 39.2658 39.7098 40.1538 40.5978 40.8758 41.3198 41.7638 42.1528 42.3748 42.8188 43.086 43.475 43.919 44.197 44.475 44.919 45.308" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Antes de iniciar el TAR conviene preparar al paciente, identiﬁ car las situaciones que puedan diﬁ cultar la adherencia correct</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 486.577816 173.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.7112 1.1552 1.4224 1.6444 2.0884 2.3664 2.8104 3.2544 3.5324 3.9764 4.2544" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">a e intentar </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 79.370114 162.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.111 1.389 1.833 2.277 2.499 2.777 2.999 3.443 3.832 4.054" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">corregirlas. </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0" font-family="g_d0_f3" font-size="1px" fill="rgb(255,127,125)"></svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 76.32 151.8381) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.339 0.783 1.172 1.394 1.672 2.116 2.56 3.004 3.448 4.115 4.559 5.003 5.281 5.725 5.947 6.169 6.613 7.002 7.446 7.668 8.112 8.556 8.834 9.056 9.5 9.944 10.222 10.444 10.888 11.332 11.554 11.943 12.387 13.054 13.498 13.942 14.22 14.664 14.886 15.108 15.552 15.774 16.218 16.662 17.106 17.55 17.828 18.272 18.716 19.105 19.327 19.771 19.993 20.437 20.659 20.881 21.275 21.831 22.331 22.553" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)"> Es fundamental evaluar periódicamente la adherencia al TAR. </svg:tspan></svg:text><svg:text transform="matrix(10.5 0 0 10.5 70.8661 118.2651) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.599 1.306 1.898 2.497 3.143 3.984 4.583 5.253 6 6.67 7.269 7.905 8.284 8.954 9.553 9.932 10.512 11.158 11.905 12.612 13.248 14.089 14.34 14.976 15.227 15.912 16.619 16.998 17.634 18.233 18.87 19.559 20.306" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">ENFERMEDADES DE TRANSMISIÓN SEXUAL</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.4335 1.6555 2.0995 2.3775 2.8215 3.2105 3.5995 3.8215 4.2655 4.7095 5.1535 5.5425 5.754 6.198 6.642 6.8535 7.1315 7.4095 7.8535 8.2975 8.6865 9.3535 9.5755 9.9645 10.1865 10.6305 11.0745 11.286 11.675 12.119 12.508 12.952 13.396 13.618 13.8295 14.0515 14.2735 14.7175 15.2175 15.4395 15.651 16.04 16.484 16.928 17.317 17.595 17.817 18.095 18.539 18.928 19.372 19.816 20.0275 20.4715 20.9155 21.127 21.516 21.96 22.404 22.626 23.07 23.514 23.792 24.236 24.4475 24.8915 25.3355 25.547 25.991 26.269 26.713 27.102 27.546 27.935 28.379 28.768 28.9795 29.2015 29.6455 29.9235 30.3675 30.7565 31.1455 31.3675 31.8115 32.2005 32.6445 33.0335 33.245 33.634 34.078 34.522 34.911 35.355 35.799 36.243 36.632 36.8435 37.2875 37.7315 38.0095 38.221 38.665 39.109 39.3205 39.7645 40.0425 40.4865 40.9305 41.3745 41.586 42.03 42.474 42.752 43.196 43.474 43.918 44.362 44.806 45.25 45.694 46.138 46.3495" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Las infecciones de transmisión sexual (ITS) constituyen un conjunto de procesos infecciosos causados por un grupo heterogéneo d</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 491.985103 96.838) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.6555 1.0995 1.5435 1.9875 2.4315 2.7095 3.1535 3.5425" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">e agentes </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 85.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.166 1.61 2.054 2.498 2.942 3.386 3.775 4.032 4.421 4.678 5.122 5.511 5.789 6.233 6.49 6.768 7.212 7.49 7.934 8.212 8.434 8.878 9.322 9.579 10.023 10.28 10.724 11.168 11.612 12.056 12.278 12.5 12.944 13.333 13.59 14.034 14.478 14.756 15.2 15.478 16.145 16.589 17.033 17.477 17.921 18.365 18.754 19.011 19.455 19.899 20.156 20.378 20.822 21.211 21.468 21.857 22.301 22.745 22.967 23.411 23.8 24.057 24.279 24.723 24.98 25.258 25.536 25.98 26.424 26.813 27.48 27.702 28.091 28.313 28.757 29.201 29.458 29.847 30.291 30.68 31.124 31.568 31.79 32.047 32.491 32.935 33.324 33.768 34.435 34.879 35.323 35.767 36.211 36.468 36.912 37.356 37.613 38.057 38.501 38.945 39.389 39.611 39.868 40.09 40.757 41.201 41.645 41.923 42.201 42.645 43.089 43.367 43.811 44.068 44.512 44.956 45.4 45.844 46.288 46.732 46.989 47.433 47.877 48.134" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">patógenos y está referido a aquellas enfermedades en las cuales la transmisión sexual desempeña un papel importante aunque no s</svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 507.566806 85.8382) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.145 1.589 1.811" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">ea el </svg:tspan></svg:text><svg:text transform="matrix(9 0 0 9 70.8661 74.838399) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.833 1.222 1.444 1.888 2.277 2.499 2.888 3.332" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">exclusivo.</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 74.8661 738.7355) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.444 0.944 1.666 1.888 2.11 2.332" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)">Familia</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.843 738.7355) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.444 0.944 1.277 1.999 2.499 2.999 3.499" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)">Fármacos</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.236 738.7355) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.225" x="0 0.556 1.056 1.778 2.278 2.778 3.056 3.556 3.889 4.111" font-family="g_d0_f5" font-size="1px" fill="rgb(64,198,192)">Comentario</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 74.8661 661.9765) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.776 1.998 2.442 2.886 3.164 3.608 3.997 4.219 4.663 5.107 5.329 5.551 5.995 6.217 6.661 6.939 7.383 7.661 8.105 8.549 8.938 9.382 9.604 9.826 10.048 10.492" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Inhibidores de la proteasa (IP)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.843202 713.825648) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.388 1.832 2.054 2.498 2.942 3.331 3.553 3.831 4.053 4.275 4.775 5.331 5.831" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Saquinavir (SQV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 719.214648) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.424 0.626 0.828 1.308 1.732 2.212 2.414 2.783 3.207 3.409 3.833 4.091 4.293 4.495 4.697 5.01 5.434 5.636 6.005 6.429 6.631 7.055 7.702 8.126 8.55 8.808 9.232 9.434 9.803 10.227 10.874 11.298 11.5 11.924 12.348 12.606 13.03 13.454 13.823 14.025 14.449 14.873 15.297 15.555 15.757 16.181 16.605 16.807 17.009 17.433 17.802 18.004 18.428 18.686 18.944 19.368 19.737 19.939 20.141 20.454 20.712" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">El RTV se utiliza solamente como potenciador de los otros (/r)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 699.093449) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.611 2.055 2.277 2.555 2.999 3.443 3.665 4.332 4.776 5.22 5.664 6.053 6.275 6.719 7.163 7.552 7.996 8.44 8.884 9.273 9.495 9.939 10.383 10.605 10.827 11.271 11.493 11.937 12.215 12.659 12.937 13.381 13.659 14.103 14.547 14.825 15.269 15.658 15.88 16.269 16.713 16.935 17.213 17.657 18.046 18.49 19.157 19.379 19.823 20.267 20.711 21.155 21.599 21.821 22.307 22.751 23.251 23.584 23.862 24.084 24.528" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Como regímenes basados en IP preferentes se recomiendan ATV/r + </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 688.893449) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 1 1.389 1.722 2.111 2.555 3.055 3.277 3.499 3.888 4.11 4.666 5.166 5.666 5.999 6.277 6.499 6.943 7.165 7.609 8.165 8.554 8.887 9.276 9.72" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">TDF/FTC, y DRV/r + TDF/FTC</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 668.772249) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.055 1.444 1.888 2.555 2.999 3.221 3.665 4.109 4.498 4.72 5.164 5.608 5.83 6.274 6.718 6.94 7.426 7.87 8.37 8.703 8.981 9.203 9.647 9.869 10.425 10.925 11.425 11.758 12.202 12.646 13.146 13.368 13.646 14.09 14.757 15.201 15.423 15.867 16.311 16.533 16.922 17.366 17.588 17.977 18.421 18.865 19.254 19.476 19.92 20.364 20.642 21.086 21.308 21.752 22.03 22.474 22.752 23.196 23.474 23.918 24.362 24.64 25.084 25.306" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">La combinación de ATV/r + ABC/3TC también se considera preferente, </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 658.572249) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.776 2.22 2.664 2.886 3.33 3.774 4.218 4.662 4.884 5.328 5.717 6.161 6.439 6.828 7.272 7.494 7.883 8.327 8.771 8.993 9.437 9.715 10.159 10.548 10.992 11.436 11.825 12.047 12.491 12.935 13.157 13.601 14.045 14.267 14.711 15.155 15.544 15.766 16.21 16.654 16.932 17.376 17.765 17.987 18.376 18.82 19.264 19.486 19.986 20.486 20.93 21.152 21.541 21.985 22.429 22.873 23.151 23.373 23.817 24.095 24.317 24.761" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">aunque debe usarse con precaución en pacientes con CVP superior a </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 648.372249) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.332 1.554 1.998 2.442 2.886 3.108 3.497 3.941 4.385 4.607 5.051 5.44 5.773 6.44" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">100.000 copias/mL</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 628.25105) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.166 1.555 1.999 2.443 2.832 3.054 3.498 3.942 4.22 4.664 5.108 5.33 5.608 6.052 6.496 6.718 7.385 7.829 8.273 8.717 9.106 9.328 9.772 9.994 10.272 10.716 10.994 11.438 11.882 12.16 12.382 12.771 13.215 13.604 13.826 14.215 14.659 15.159 15.492 15.77 15.992 16.436 16.658 17.102 17.658 18.047 18.38 18.769 19.213 19.713 19.935 20.379 20.601 21.157 21.657 22.157 22.49 22.934 23.378 23.878 24.1 24.322 24.544 24.988 25.377" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Se consideran regímenes alternativos LPV/r + TDF/FTC o ABC/3TC). Es </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 618.051049) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.943 2.165 2.609 2.831 3.275 3.553 3.775 3.997 4.219 4.552 4.996 5.274 5.496 5.774 6.218 6.885 7.329 7.551 7.995 8.439 8.661 8.883 9.327 9.549 9.938 10.382 11.049 11.493 11.715 12.159 12.603 12.992 13.214 13.658 14.102 14.324 14.88 15.38 15.88 16.213 16.491 16.713 17.157 17.379 17.935 18.435 18.935 19.268 19.712 20.156 20.656 20.878 21.1 21.544 21.988 22.432 22.876 23.32 23.764 23.986 24.43 24.874 25.096 25.54 25.984" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">posible utilizar también la combinación DRV/r + ABC/3TC, aunque no ha </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.23585 607.851049) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.611 1.055 1.499 1.721 1.999 2.443 2.721 3.388 3.832 4.054 4.721 5.165 5.609 5.887 6.331 6.553 6.775 7.219 7.608 8.052 8.441 8.719 8.941 9.385 9.829 10.273 10.717 10.939 11.383 11.827 12.049 12.493 12.715 13.159 13.603 14.047 14.491 14.713 15.157 15.601 15.99 16.434 16.823 17.267 17.489 17.878 18.1 18.322 18.766 18.988 19.377" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">sido formalmente investigada en ningún ensayo clínico</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.843202 688.312897) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.776 2.22 2.609 2.831 3.109 3.331 3.553 3.775 4.331 4.831" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Indinavir (IDV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.843202 662.801846) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.722 1 1.444 1.888 2.332 2.721 2.943 3.221 3.443 3.665 4.165 4.609 5.109" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Ritonavir (RTV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.843202 637.289946) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.666 2.333 2.777 3.055 3.499 3.943 4.387 4.776 4.998 5.276 5.498 5.72 6.109 6.553 7.053" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Fosamprenavir (FPV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.843202 610.951847) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.394 0.616 1.06 1.338 1.782 2.226 2.67 3.059 3.281 3.559 3.781 4.003 4.447 4.891 5.391" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Tipranavir (TPV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.622 588.6795) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.499 1.943 2.387 2.776 2.998 3.276 3.498 3.72 4.109 4.553 5.053 11.811 12.235 12.721 13.165 13.665 13.887 14.276 14.498 15.054 15.554 16.054 16.276 16.72 17.164 17.608 18.052 18.496 18.94 19.162 19.551 19.995 20.273 20.495 20.939 21.383 21.661 22.105 22.549 22.938 23.16 23.604 24.048 24.492 24.881 25.103 25.325 25.769 26.213 26.435 26.824 27.102 27.324 27.768 28.046 28.49 29.157 29.601 30.045 30.323 30.767 30.989 31.378 31.822 32.266 32.488 32.932 33.376 33.82 34.042 34.709 35.153 35.375 35.819 36.263" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Lopinavir (LPV)EATV y DRV pueden ser potenciados indistintamente con 100 mg de </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 578.4795) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.444 1.666 2.11 2.332 2.776 3.22 3.664 3.886 4.553 4.997 5.219 5.663 6.107 6.329 6.718 7.162 7.606 7.828 8.217 8.439 8.828 9.106 9.55 9.828 10.05 10.272 10.772 11.328 11.828 12.05" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">RTV o 150 mg de cobicistat (COBI)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 560.342199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.333 1.666 1.944 2.166 2.61 2.832 3.276 3.72 4.22 4.442 4.831 5.053 5.442 5.886 6.386 6.719 6.997 7.219 7.663 7.885 8.385 8.941 9.33 9.552 9.996 10.44 10.884 11.328 11.772 12.216 12.438 12.827 13.271 13.549 13.771 14.215 14.659 15.103 15.325 15.769 15.991 16.269 16.713 16.991 17.435 17.879 18.157 18.379 18.768 19.212 19.434 19.878 20.1 20.322 20.766 20.988 21.266 21.544 21.766 22.21 22.432 22.876 23.098 23.376 23.82 24.098 24.542 24.986 25.208 25.652" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">LPV/r + 3TC y LPV/r + RAL pueden ser una alternativa a la triple terapia </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 550.142199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.277 1.666 2.11 2.554 2.943 3.165 3.609 4.053 4.497 4.719 4.941 5.33 5.774 6.218 6.662 7.106 7.55 7.772 8.216 8.66 8.882 9.271 9.715 9.937 10.381 10.825 11.269 11.713 12.157 12.379 12.823 13.101 13.323 13.545 13.767 14.1 14.544 14.822 15.044 15.488 16.044 16.433 16.655 17.099 17.321 17.543 18.099 18.599 19.099" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">convencional cuando no se pueda utilizar TDF ni ABC </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.622 568.836249) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 0.834 1.278 1.611 2.055 2.499 2.943 3.332 3.554 3.832 4.054 4.276 4.762 5.206 5.706" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Atazanavir (ATV)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.622 548.99385) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.722 2.166 2.61 2.999 3.221 3.499 3.721 3.943 4.499 4.999 5.499 5.721" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Darunavir (DRV) </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 74.865898 505.447502) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.776 1.998 2.442 2.886 3.164 3.608 3.997 4.219 4.663 5.107 5.329 5.551 5.995 6.217 6.439 6.883 7.161 7.605 8.049 8.327 8.771 9.16 9.604 9.826 10.048 10.27 10.714 10.936 11.38 11.658" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Inhibidores de la integrasa (InInt)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.622 529.150601) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.166 1.444 1.888 2.332 2.61 3.054 3.443 3.665 3.943 4.165 4.387 4.887 5.443 5.832 11.811 12.311 12.867 13.256 13.478 13.922 14.366 14.81 15.254 15.698 15.92 16.364 17.031 17.475 17.697 18.141 18.585 18.863 19.252 19.696 19.918 20.307 20.751 21.418 21.862 22.084 22.362 22.64 23.084 23.362 23.806 24.473 24.695 25.139 25.583 25.861 26.305 26.527 26.971 27.415 27.637 27.859 28.303 28.525 28.914 29.136 29.58 29.802 30.191 30.635 31.302 31.746 31.968 32.412 32.856 33.3 33.744 33.966 34.355 34.799 35.243 35.465 35.909 36.465 36.854" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Raltegravir (RAL)RAL puede emplearse como tratamiento de inicio combinado con TDF/</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 518.950601) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.333 1.555 1.999 2.221 2.777 3.277 3.777 4.11 4.554 4.998" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">FTC o ABC/3TC</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 503.081951) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.389 0.833 1.222 1.444 1.833 2.277 2.944 3.388 3.61 4.054 4.498 4.887 5.109 5.553 5.997 6.441 6.83 7.052 7.496 7.996 8.552 8.885 9.385 9.941 10.441 10.663 10.996 11.44 11.996 12.385 12.718 13.107 13.551 14.051 14.273 14.495 14.939 15.383 15.827 16.049 16.493 16.937 17.159 17.603 18.047 18.491 18.935 19.157 19.601 19.99 20.434 20.712 21.101 21.545 21.767 22.211 22.655" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Las combinaciones EVG/COBI/TDF/FTC (que no debe usarse en </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 492.881951) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.277 1.499 1.943 2.387 2.665 3.109 3.498 3.72 4.109 4.553 4.997 5.219 5.608 6.164 6.386 6.83 7.219 7.497 7.719 8.386 8.83 9.274 9.718 9.94 10.607 11.051 11.495 11.939 12.217 12.439 12.883 13.327 13.549 13.993 14.437 14.659 15.326 15.715 16.048 16.715 16.937 17.381 17.603 17.825 18.214 18.436 18.992 19.436 19.992 20.214 20.603 21.047 21.491 21.713 22.269 22.769 23.269 23.602 24.046 24.49 24.99 25.212 25.656" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">pacientes con FG estimado menor de 70 mL/min) y DTG con ABC/3TC o </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.01635 482.681951) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 1 1.389 1.722 2.111 2.555 3.055 3.277 3.721 4.165 4.609 5.053 5.497 5.941 6.163 6.607 6.885 7.107 7.329 7.551 7.884 8.328 8.606 8.995 9.439 9.661 10.05 10.494 11.161 11.605 11.827 12.105 12.549 12.993 13.215 13.882 14.326 14.77 15.214 15.603 15.825 16.269 16.713 16.935 17.329 17.885 18.385 18.607 19.051 19.495 19.717 19.939 20.383 20.605 20.994 21.216" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">TDF/FTC pueden utilizarse como regímenes de TAR de inicio</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.622 506.4743) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.666 1.055 1.277 1.555 1.999 2.443 2.721 3.165 3.554 3.776 4.054 4.276 4.498 4.942 5.442 5.998" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Elvitegravir (EVG)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 195.622 483.797149) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.222 1.666 1.944 2.388 2.832 3.11 3.554 3.943 4.165 4.443 4.665 4.887 5.443 5.887 6.443" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Dolutegravir (DTG)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 74.865898 450.7092) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.556 1 1.278 1.722 2.166 2.61 3.054 3.276 3.665 3.943 4.387 4.776 4.998 5.498 5.998 6.498 14.207 14.985 15.429 15.707 16.151 16.54 16.762 17.04 17.484 17.873 18.095 18.317 19.095 19.595 20.095" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Antagonistas CCR5Maraviroc (MVC)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.015491 467.0122) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.758 1.238 1.718 1.92 2.289 2.713 2.915 3.339 3.763 4.187 4.611 4.813 5.237 5.495 5.697 5.899 6.101 6.414 6.838 7.096 7.298 7.722 8.091 8.46 8.662 9.086 9.455 9.657 10.026 10.45 11.097 11.521 11.945 12.203 12.627 12.829 13.253 13.677 13.879 14.081 14.505 14.874 15.076 15.5 15.924 16.293 16.495 16.919 17.343 17.601 18.025 18.394 18.596 18.798 19.222 19.48 19.904 20.273 20.531 20.955 21.379 21.803 22.172 22.374 22.798 23.222 23.48 23.682 24.051 24.475 24.899 25.323 25.712" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">MVC se debe utilizar exclusivamente en los pacientes infectados por cepas </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.015491 456.812199) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.48 0.904 1.106 1.53 1.954 2.156 2.636 2.838 3.374 3.576 3.778 4.202 4.626 5.05 5.252 5.676 5.934 6.136 6.338 6.54 6.853 7.277 7.701 7.903 8.327 8.529 8.731 9.1 9.524 9.782 10.04 10.464 10.833 11.257 11.681 11.939 12.363 12.621 12.823 13.303 13.783 14.263 14.687 14.889 15.313 15.737 15.995 16.419 16.621 17.045 17.469 17.893 18.317 18.575 18.833 19.257 19.515 19.717 20.141 20.565 20.767 20.969 21.393 21.762 21.964 22.333 22.757 22.959 23.383 23.585 24.009" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">R5 de VIH, que utilizan el correceptor CCR5 para penetrar en las células</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.015491 440.941849) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.5 0.944 1.166 1.61 1.888 2.11 2.332 2.554 2.887 3.331 3.553 3.997 4.441 4.663 5.107 5.551 5.995 6.273 6.717 7.106 7.328 7.772 8.216 8.438 8.716 9.16 9.549 9.938 10.382 10.66 11.104 11.326 11.715 12.159 12.603 13.047 13.491 13.935 14.157 14.601 15.045 15.489 15.711 15.989 16.433 16.655 16.877 17.321 17.765 18.209 18.431 18.875 19.153 19.431 19.875 20.264 20.486 20.764 21.208 21.652 21.874 22.541 22.985 23.429 23.873" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Se utiliza en pautas de rescate cuando han fallado otros regímenes</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 74.865898 412.511898) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.222 0.666 1.11 1.332 1.776 1.998 2.442 2.886 3.164 3.608 3.997 4.219 4.663 5.107 5.329 5.551 5.995 6.217 6.495 6.939 7.328 7.55 7.994 8.438 8.66 8.882 9.104 9.493 14.207 14.651 15.095 15.373 15.817 16.206 16.428 16.706 16.984 17.206 17.65 18.094 18.316 18.538 18.982 19.593 19.982" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Inhibidores de la fusión (IF)Enfuvirtida (ENF)</svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.015491 419.673148) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.778 1.222 1.611 1.833 2.277 2.721 3.11 3.554 3.776 4.22 4.498 4.72 4.942 5.164 5.497 5.941 6.385 6.829 7.051 7.495 7.939 8.217 8.439 8.883 9.161 9.605 9.994 10.216 10.605 11.049 11.327 11.549 11.993 12.437 13.104 13.326 13.77 13.992 14.381 14.659 14.937 15.381 15.77 15.992 16.436 16.88 17.102 17.546 17.99 18.268 18.712 19.156 19.434 19.878 20.156 20.6 20.822 21.044 21.266 21.766 22.21 22.432 22.876 23.543 23.987 24.431 24.709 25.153" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">Muy poco utilizado por precisar administración parenteral. Solamente </svg:tspan></svg:text><svg:text transform="matrix(8.5 0 0 8.5 296.015491 409.473148) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.221" x="0 0.444 0.888 1.11 1.388 1.832 2.221 2.61 3.054 3.332 3.776" font-family="g_d0_f3" font-size="1px" fill="rgb(43,46,52)">en rescates</svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 86.0141 759.7067) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.244" x="0 0.569 1.081 1.443 2.168 2.68 3.119 3.663 4.203 4.582 5.094 5.642 5.98 6.196 6.558 6.912 7.46 7.798 8.152 8.696 9.193 9.409 9.747 10.259 10.471 11.019 11.559 11.938 12.485 12.823 13.039 13.251 13.467 13.928 14.44 14.969 15.513 16.053 16.432 16.98 17.528 17.907 18.119 18.631 19.01 19.522 19.961 20.299 20.846 21.358 21.57 21.786 22.315 22.827 23.356" font-family="g_d0_f4" font-size="1px" fill="rgb(64,198,192)">Fármacos antirretrovirales utilizados en la actualidad </svg:tspan></svg:text><svg:text transform="matrix(9.5 0 0 9.5 311.492801 759.5737) scale(1, -1)" xml:space="preserve"><svg:tspan y="-0.258" x="0 0.226 0.66 1.177 1.699 2.013 2.195 2.717 3.237 3.723 4.157 4.339 4.856 5.378" font-family="g_d0_f1" font-size="1px" fill="rgb(64,198,192)">(continuación)</svg:tspan></svg:text></svg:g></svg:g></svg:g></svg:svg>